Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2008
04/10/2008WO2008022716A3 Screening method for gpcr ligands
04/10/2008WO2008021484A3 Assay system to identify therapeutic agents
04/10/2008WO2008019375A3 Proteomic patterns of cancer prognostic and predictive signatures
04/10/2008WO2008012650A3 An immunochromatography device for the diagnosis of diseases in a sample
04/10/2008WO2008010105A3 Device for analyzing samples including a gas evolving means
04/10/2008WO2008009867A3 Epr-based detection, identification and quantification of free radicals, sampling device and kit
04/10/2008WO2008009855A3 Modulators of sc4mol in the treatment of acne or of hyperseborrhoea
04/10/2008WO2008007159B1 Measurement of complement activation products on antigen arrays
04/10/2008WO2008003707A3 Minimized small peptides with high affinity for factor viii and factor viii-like proteins
04/10/2008WO2008003309A3 Method for the identification of plastics
04/10/2008WO2008001222A3 Analysis of mannosamine-containing capsular saccharides
04/10/2008WO2007147600A3 Differential il-4 and/or il-10 cytokine expression in human cancer
04/10/2008WO2007146616A3 Devices and methods for detection of markers of axial pain with or without radiculopathy
04/10/2008WO2007145940A3 High-throughput rna structure analysis
04/10/2008WO2007144491A3 Mobile unit for the treatment of raw water
04/10/2008WO2007142987A3 Mammary stem cell marker
04/10/2008WO2007140971A3 Cell adhesion proteins as biomarker for alzheimer's disease
04/10/2008WO2007138066A3 Method of screening for compounds that alter skin and/or hair pigmentation
04/10/2008WO2007134818A3 Method for diagnosing mitochondrial dysfunction
04/10/2008WO2007132430A3 Porphyrinogen derivatives useful as explosives detection markers
04/10/2008WO2007107774A3 Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
04/10/2008WO2007096199A3 Differential diagnostics and therapy of virally induced heart muscle disease
04/10/2008WO2007092457A3 Ligands for virus channel proteins
04/10/2008WO2007087312A3 Molecular counting
04/10/2008WO2007084715A3 Tat-031 and methods of assessing and treating cancer
04/10/2008WO2007084397A3 Processing of slpi by chymase
04/10/2008WO2007083116A3 Target
04/10/2008WO2007070761A3 Method for encoding and screening combinatorial libraries
04/10/2008WO2007048985A3 Substance for restoring normal co-expression and interaction between lox and nrage proteins
04/10/2008WO2007026171A8 Vdcc gamma-8 ion channel
04/10/2008WO2005007875A3 Enhanced promoters for synthesis of small hairpin rna
04/10/2008US20080086291 Spatial Profiling of Proteins Using Hydrophobic Moments
04/10/2008US20080086045 Method and device for monitoring platelet function
04/10/2008US20080085995 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
04/10/2008US20080085994 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
04/10/2008US20080085993 Fluorescent Compounds
04/10/2008US20080085918 Fitness assay and associated methods
04/10/2008US20080085878 Superoxide dismutase-2 expression and modulation for glaucoma diagnosis and therapy
04/10/2008US20080085861 Gas1 polypeptides
04/10/2008US20080085859 Drug Promoting Ceramide Transport, Base Sequence for Producing the Drug, Method of Measuring Activity of Promoting Ceramide Release and Method of Measuring Activity of Promoting Intermembrane Ceramide Transfer
04/10/2008US20080085838 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
04/10/2008US20080085564 Micro-pixelated fluid-assay structure with on-board addressable, pixel-specific functionalization
04/10/2008US20080085563 Using azo dye as fluorescent tool in quantifying concentration of gadolinium in mammalian cells; diagnosing urogenital disorders
04/10/2008US20080085562 Using azo dye as fluorescent tool in quantifying concentration of gadolinium in mammalian cells; diagnosing urogenital disorders
04/10/2008US20080085561 Biosensor and blood component analytical method
04/10/2008US20080085560 Lysing Reagent For Simultaneous Enumeration Of Different Types Of Blood Cells In A Blood Sample
04/10/2008US20080085559 Micro-pixelated active-matrix fluid-assay performance
04/10/2008US20080085557 Human Cancer Stem Cell Culture Compositions Comprising Erbb2 Variants and Methods of use Thereof
04/10/2008US20080085532 Method for determining the immune status of a subject
04/10/2008US20080085529 Fluorescence assay for kinase activity
04/10/2008US20080085526 Using concentration of hepatic fibrosis associated polypeptide (HFAP) as diagnostic/prognostic tool in evaluating liver disorders
04/10/2008US20080085525 Chromatographic Analysis Devices And Test Kits
04/10/2008US20080085524 Methods for diagnosing irritable bowel syndrome
04/10/2008US20080085523 Method and Device for Trichomonas Detection
04/10/2008US20080085519 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
04/10/2008US20080085517 Use of haploid genomes for genetic diagnosis, modification and multiplication
04/10/2008US20080085516 Using mutation in glucose transport protein as evaluative tool in diagnosing/prognosing diabbetic and eating disorders
04/10/2008US20080085512 Using non-polar organic solvent and plasma as tool in preparation of solid support for biopolymer analysis
04/10/2008US20080085510 Human ron-related gene variant associated with cancers
04/10/2008US20080085509 Single copy genomic hybridization probes and method of generating same
04/10/2008US20080085508 Non-nucleic acid based biobarcode assay for detection of biological materials
04/10/2008US20080085507 Chromatographic column for detection of biopolymers in solution
04/10/2008US20080085339 Amino Acid Oligomer Dietary Supplement
04/10/2008US20080085324 Compositions and methods for detecting and treating renal injury and inflammation
04/10/2008US20080085283 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
04/10/2008US20080085282 Methods of detecting and controlling mucoid pseudomonas biofilm production
04/10/2008US20080085279 Murine double mutant binding protein (MTBP) inhibitor for use as tool in treatment and prevention of cell proliferative disorders
04/10/2008US20080085277 Novel antigen-binding polypeptides and their uses
04/10/2008US20080085266 Using cancer antigen 125 as tool in generating transmembrane serine protease inhibitory compound for treatment of urogenital cell proliferative disorders
04/10/2008US20080085262 Purified mammalian cytokines; related reagents and methods
04/10/2008US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's
04/10/2008US20080085243 Molecular markers for determining taxane responsiveness
04/10/2008US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids
04/10/2008US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc
04/10/2008US20080085240 by determining the relative amount of metabolite CO2 isotope exhaled; to assess the metabolic activity of drug metabolizing enzyme; theranostics; pharmacogenetics
04/10/2008US20080085213 Cartridge-type reagent chip analyzer
04/10/2008US20080083773 Contact Connector Assembly For A Sensor-Dispensing Instrument
04/10/2008US20080083619 Biosensor and blood component analytical method
04/10/2008US20080083265 Carbon dioxide detector having borosilicate substrate
04/10/2008DE19882693B4 On-line-Sensoranordnung zum Messen eines Bioanalyten wie etwa Lactat On-line sensor arrangement for measuring a bioanalytes such as lactate
04/10/2008DE19857215B4 Multiküvettenrotor Multi-cell rotor
04/10/2008DE112005003145T5 Erfassung von verstärkten Multiplexsignalen durch oberflächenverstärkte Raman-Spektroskopie (SERS) Detection of amplified multiplex signals by surface enhanced Raman spectroscopy (SERS)
04/10/2008DE102007045837A1 Verfahren zum Ermitteln von Qualitätsverlust eines Schmieröls Method for determining quality loss of a lubricating oil
04/10/2008DE102006050021A1 Top-down protein analysis process for mass spectrometry involves fragmenting proton ions and part protein removal from ions to produce mixture for mass spectrum
04/10/2008DE102004031570B4 Objektträgervorrichtung zur Untersuchung mit einem Mikroskop Slide device for examination with a microscope
04/10/2008DE102004013161B4 Mikrofluidik-Chip Microfluidic chip
04/10/2008CA2672015A1 General prognostic parameters for tumour patients
04/10/2008CA2669994A1 Cancer immunotherapy predictive parameters
04/10/2008CA2665683A1 A method of generating a platelet reactivity profile for an individual
04/10/2008CA2665387A1 Grp78 as a predictor of responsiveness to therapeutic agents
04/10/2008CA2665365A1 Compositions and methods for detecting and treating renal injury and inflammation
04/10/2008CA2665356A1 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
04/10/2008CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
04/10/2008CA2665324A1 Fluoro-substituted benzoxazole polymethine dyes
04/10/2008CA2665205A1 Preparation method
04/10/2008CA2665183A1 Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
04/10/2008CA2665100A1 Methods of detecting and monitoring cancer using 3d analysis of centromeres
04/10/2008CA2665053A1 Methods and devices for simultaneously monitoring the characteristics of microscopic particles in suspension and the characteristics of soluble components during reactions
04/10/2008CA2664356A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
04/10/2008CA2658618A1 Novel gene disruptions, compositions and methods relating thereto